000			01948 a2200577 4500
005			20250516052615.0
264		0	_c20120215
008			201202s 0 0 eng d
022			_a1932-6203
024	7		_a10.1371/journal.pone.0023429 _2doi
040			_aNLM _beng _cNLM
100	1		_aSinnberg, Tobias
245	0	0	_aβ-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance. _h[electronic resource]
260			_bPloS one _c2011
300			_ae23429 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Movement _xdrug effects
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aCisplatin _xpharmacology
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDoxycycline _xpharmacology
650	0	4	_aDrug Synergism
650	0	4	_aHCT116 Cells
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMelanocytes _xcytology
650	0	4	_aMelanoma _xgenetics
650	0	4	_aMelanoma, Experimental _xgenetics
650	0	4	_aMice
650	0	4	_aMice, SCID
650	0	4	_aPerylene _xanalogs & derivatives
650	0	4	_aRNA Interference
650	0	4	_aSignal Transduction
650	0	4	_aTCF Transcription Factors _xantagonists & inhibitors
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aXenograft Model Antitumor Assays
650	0	4	_abeta Catenin _xantagonists & inhibitors
700	1		_aMenzel, Moritz
700	1		_aEwerth, Daniel
700	1		_aSauer, Birgit
700	1		_aSchwarz, Michael
700	1		_aSchaller, Martin
700	1		_aGarbe, Claus
700	1		_aSchittek, Birgit
773	0		_tPloS one _gvol. 6 _gno. 8 _gp. e23429
856	4	0	_uhttps://doi.org/10.1371/journal.pone.0023429 _zAvailable from publisher's website
999			_c21101253 _d21101253